Drug recall · December 14, 2022
Desmopressin Acetate Tablet recall
Why: Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.
- Lots / codes
Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023
- Quantity
- 9 boxes
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Product was distributed to two different customers in MI.
- Initiated
- December 5, 2022 · Voluntary: Firm initiated
- Classified
- December 7, 2022
- Reported
- December 14, 2022
- Ended
- February 3, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Desmopressin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.